stand and de-liver, page-19

Bevter

Solagran are inviting 'downramping', they have left the doors wide open for adverse comments. Even the most staunch shareholders must feel frustrated with the lack of substantial information.

Their promises are reminding me of that line from Through the Looking Glass, "jam yesterday, jam tomorrow, but never jam today."

I'm hoping, like many who contribute to HC, that Ropren lives up to claims both medically and fiscally.

Everyone is entitled to express their views...'so called rampers, downrampers and all those in between.